Physician profile
Baher B Maximos
NPI 1427291574
$7,869.08
in general payments reported to CMS, 2019-2025
26 companies · $2,736 in 2025
The $2,736 reported for 2025 was more than what 86% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,889 · 2020: $1,810 · 2021: $225 · 2022: $546 · 2023: $501 · 2024: $163 · 2025: $2,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,796 · Travel and Lodging: $1,285 · Education: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,796.13 |
| Travel and Lodging | $1,285.22 |
| Education | $318.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $2,242.79 | 2025 | Aptus |
| Axogen | $1,846.84 | 2019-2025 | Avance Nerve Graft |
| Acelrx Pharmaceuticals, INC. | $1,497.52 | 2020-2022 | |
| Biopro, INC. | $487.59 | 2023-2025 | Mod Thumb |
| Anika Therapeutics, INC. | $344.98 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $206.01 | 2020-2022 | |
| Extremity Medical | $187.57 | 2020 | |
| Endo Pharmaceuticals INC. | $179.88 | 2019-2021 | |
| Acumed LLC | $138.92 | 2025 | Acumed |
| Abbott Laboratories | $110.69 | 2019 | |
| Ensemble Orthopedics, INC | $108.66 | 2024 | Ensemble Cmc |
| Medinc of Texas | $89.39 | 2023 | |
| Zimmer Biomet Holdings, INC. | $59.70 | 2019 | |
| Stryker Corporation | $52.64 | 2022 | |
| Alafair Biosciences, INC. | $44.83 | 2023 | Versawrap |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $41.02 | 2023-2024 | |
| Baudax Bio INC. | $40.92 | 2021 | |
| Globus Medical, INC. | $30.63 | 2024 | Distal Radius II |
| Boston Scientific Corporation | $30.52 | 2023 | Wavewriter Alpha Prime 16 |
| Integra Lifesciences Corporation | $22.54 | 2021 | |
| Eagle Pharmaceuticals, INC. | $22.50 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.44 | 2025 | |
| Titan Spine, LLC | $20.30 | 2019 | |
| Acacia Pharma INC | $18.66 | 2021 | |
| Bioventus LLC | $16.55 | 2021 | |
| Trimed, INC. | $4.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baher Maximos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.